drugset / Trial / NCT02235311

Optimal Dose of Proton Pump Inhibitors Following an Upper Gastrointestinal Bleed

NCT02235311

Terminated 3 enrolled University of Missouri-Columbia
RandomizedParallel-groupSingle-blindTreatment

Summary

Despite recommendations from clinical practice guidelines to discharge patients from the hospital on once daily proton pump inhibitors after acute management of UGIB, clinical practice is to use twice daily proton pump inhibitor therapy. The objective of this study will be to assess whether or not once daily pantoprazole is non-inferior to twice daily pantoprazole in ulcer healing with a dose of once daily versus twice daily proton-pump inhibitor following an upper gastrointestinal bleed. Additionally, this study will observe for any potential difference in safety for once daily versus twice daily proton pump inhibitors.

Timeline

Start
2014-10
Primary completion
2015-08-17
Completion
2015-08-17

Drugs

EvaluationDrugModalityDoseRoute
Comparator Pantoprazole Other / unclassified 40 mg Oral

Indications

No indication recorded.